Published On Apr 8, 2024
Presented By: Kyle Nilson, PhD
Speaker Biography: Kyle Nilson, PhD, is a sequencing-focused molecular biologist with a background in biochemistry and technical support. As a field software trainer at QIAGEN Digital Insights, Dr. Nilson works closely with QIAGEN’s global bioinformatics team to provide direct customer support and assist with software training, implementation, and optimization. He earned his Ph.D. in molecular and cellular biology from the University of Iowa, where he studied the regulation of RNA polymerase II transcription and co-transcriptional mRNA processing. Dr. Nilson then completed his postdoctoral training at Penn State and Cornell University, focusing exclusively on next-generation sequencing method development to study chromatin.
Webinar: Leveraging Expert-Curated Knowledge from COSMIC and QIAGEN to Avoid Pitfalls, Qualify Candidate Drug Targets, and Accelerate Early Discovery
Webinar Abstract: In this talk, our experts discuss how biopharmaceutical companies can leverage key genomic, biomedical, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN, and how to use these resources to better predict cancer-driving effects of mutations, identify available drugs that target specific variants, and accelerate indication expansion and repurposing of existing cancer therapies.
Labroots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc